← All trials
NCT01577784
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 1, 2012
- Primary completion
- Oct 1, 2014
- Completion date
- Oct 1, 2015
- First posted
- —
- Last posted
- —
- Enrollment
- 27
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- Associació per a la Recerca Oncologica, SpainLead sponsor
- Hospital Universitario Central de AsturiasOverall official - principal investigator
- Hospital Son EspasesOverall official - principal investigator
- University of BarcelonaOverall official - principal investigator
- Universidad Autonoma de BarcelonaOverall official - principal investigator
- Universidad Complutense de MadridOverall official - principal investigator
- Universidad Autonoma de BarcelonaStudy chair
- Trial Form Support S.L.Collaborator
- Badalona Hospital Germans Trias i PujolOverall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.